Literature DB >> 32617153

Reproductive Health and Nonalcoholic Fatty Liver Disease in Women: Considerations Across the Reproductive Lifespan.

Monika Sarkar1, Ayako Suzuki2.   

Abstract

Entities:  

Year:  2020        PMID： 32617153      PMCID： PMC7326635          DOI： 10.1002/cld.955

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  31 in total

1.  The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

2.  Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents.

Authors:  Oyekoya T Ayonrinde; Leon A Adams; Trevor A Mori; Lawrence J Beilin; Nicholas de Klerk; Craig E Pennell; Scott White; John K Olynyk
Journal:  Hepatology       Date:  2017-11-13       Impact factor: 17.425

3.  Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study.

Authors:  Alina M Allen; Terry M Therneau; Joseph J Larson; Alexandra Coward; Virend K Somers; Patrick S Kamath
Journal:  Hepatology       Date:  2018-03-23       Impact factor: 17.425

4.  Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.

Authors:  Richard S Legro; Carol L Gnatuk; Allen R Kunselman; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2005-03-29       Impact factor: 5.958

5.  Effect of insulin on fat metabolism during and after normal pregnancy.

Authors:  E Sivan; C J Homko; X Chen; E A Reece; G Boden
Journal:  Diabetes       Date:  1999-04       Impact factor: 9.461

6.  Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus: A Prospective Cohort Study.

Authors:  Erica P Gunderson; Shanta R Hurston; Xian Ning; Joan C Lo; Yvonne Crites; David Walton; Kathryn G Dewey; Robert A Azevedo; Stephen Young; Gary Fox; Cathie C Elmasian; Nora Salvador; Michael Lum; Barbara Sternfeld; Charles P Quesenberry
Journal:  Ann Intern Med       Date:  2015-11-24       Impact factor: 25.391

7.  Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance.

Authors:  Helen Jones; Victoria S Sprung; Christopher J A Pugh; Christina Daousi; Andrew Irwin; Nabil Aziz; Valerie L Adams; E Louise Thomas; Jimmy D Bell; Graham J Kemp; Daniel J Cuthbertson
Journal:  J Clin Endocrinol Metab       Date:  2012-07-26       Impact factor: 5.958

8.  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Authors:  Cristián Cerda; Rosa María Pérez-Ayuso; Arnoldo Riquelme; Alejandro Soza; Paulina Villaseca; Teresa Sir-Petermann; Manuel Espinoza; Margarita Pizarro; Nancy Solis; Juan Francisco Miquel; Marco Arrese
Journal:  J Hepatol       Date:  2007-05-24       Impact factor: 25.083

9.  Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010.

Authors:  J A Lavery; A M Friedman; K M Keyes; J D Wright; C V Ananth
Journal:  BJOG       Date:  2016-08-11       Impact factor: 6.531

10.  Prevalence of hepatic steatosis in women with polycystic ovary syndrome.

Authors:  Ritu Karoli; Jalees Fatima; Ashok Chandra; Uma Gupta; Faraz-Ul Islam; Gagandeep Singh
Journal:  J Hum Reprod Sci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.